Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07415772 · ClinicalTrials.gov registry record · NA
Effect of cTBS on Startle and TMS-evoked BOLD
A NA study, sponsored by University of Pennsylvania.
- Not yet
- Registry status
- NA
- Development phase
- 140
- Enrollment target
NCT07415772: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT07415772 is a NA study that has not yet begun recruiting, run by University of Pennsylvania. The registered enrollment target is 140 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07415772, a NA study, has not yet begun recruiting, sponsored by University of Pennsylvania.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
Study Summary
The right dorsolateral prefrontal cortex (dlPFC) is increasingly being targeted with transcranial magnetic stimulation (TMS) to reduce anxiety expression; however, there is little mechanistic evidence supporting an optimized treatment protocol. Thus, the objective of the current project is to develop an interleaved TMS/fMRI that can assess the effect of neuromodulatory (potentially therapeutic) TMS protocols on neural and behavioral measures related to anxiety expression. PUBLIC HEALTH RELEVANCE: These results will yield direct evidence that 1 Hz and cTBS modulate brain activity associated with anxiety expression and regulation, thus informing novel TMS based anxiety treatments.
Interventions
- DEVICE Sham TMS
- DEVICE Active TMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2031-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07415772
The ClinicalTrials.gov registry entry for NCT07415772 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham TMS is the first listed.
NCT07415772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07415772 about?
NCT07415772 is a clinical study titled "Effect of cTBS on Startle and TMS-evoked BOLD". The right dorsolateral prefrontal cortex (dlPFC) is increasingly being targeted with transcranial magnetic stimulation (TMS) to reduce anxiety expression; however, there is little mechanistic evidence supporting an optimized treatment protocol. Thus, the objective of the current project is to develo...
What is the current status of trial NCT07415772?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2026-07-01. Estimated completion is 2031-06-30.
What interventions are being tested in trial NCT07415772?
The interventions under investigation include: Sham TMS (DEVICE), Active TMS (DEVICE).
Who is sponsoring clinical trial NCT07415772?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.